Clearance Summary
RIA-GNOST INSULIN received FDA 510(k) clearance under submission number K890837, sponsored by Cambridge Medical Technology. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1989-04-26.
- Submission: K890837
- Applicant / Sponsor: Cambridge Medical Technology
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class I
- Regulation citation: 21 CFR 862.1405
- Decision date: 1989-04-26
Classification & Regulation
This clearance is catalogued under FDA product code CFP and 21 CFR 862.1405, within the Clinical Chemistry review panel as a Class I device.